Загрузка...
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers
PURPOSE: Advanced cancers of the bile duct and gallbladder carry an ominous prognosis. Rebeccamycin analogue (RA) is a novel antitumor antibiotic where phase I trials suggested clinical efficacy in patients with biliary cancers. METHODS: The primary objective was to determine the response rate to RA...
Сохранить в:
| Опубликовано в: : | Cancer Chemother Pharmacol |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4220168/ https://ncbi.nlm.nih.gov/pubmed/19399502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-009-1005-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|